2-(4-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACZFHP985
CAS No. :
2128285-49-2
Molecular Formula :
C16H18BClO2
Molecular Weight :
288.58

IUPAC Name:2-(4-chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$60.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(4-chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC16H18BClO2
Molecular Weight288.58
SMILESCC1(C)OB(C2=CC=C(Cl)C3=CC=CC=C23)OC1(C)C
InChI KeyGYUPNPHOZCUMSI-UHFFFAOYSA-N
Synonym1-Chloronaphthalene-4-boronic acid, pinacol ester;1,3,2-Dioxaborolane, 2-(4-chloro-1-naphthalenyl)-4,4,5,5-tetramethyl-;2-(4-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS No.2128285-49-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACZFHP985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZFHP985 route product structure diagram
    ACZFHP9852128285-49-2
Inquiry

2. ACZFHP985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACPBXR546 route compound structure diagram
    ACPBXR54653220-82-9 In Stock
  4. Then
  5. ACZFHP985 route product structure diagram
    ACZFHP9852128285-49-2
Inquiry

Comments (0)